Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 0.6979 Delayed Data As of 3:59pm ET |  +0.0284 / +4.24%Today’s Change | 0.49 Today|||52-Week Range 2.77 | -47.13% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $97.0M |
Company Description
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Contact Information
Nabriva Therapeutics Plc 25-28 North Wall Quay Dublin Dublin 1 |
Employees
Shareholders
| Individual stakeholders | 8.03% |
| Other institutional | 6.94% |
| Mutual fund holders | 6.85% |
Top Executives
| There are no executives to display. |
